1094 related articles for article (PubMed ID: 24200905)
1. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
2. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
3. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
4. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
[TBL] [Abstract][Full Text] [Related]
5. Rho-Kinase Inhibition During Early Cardiac Development Causes Arrhythmogenic Right Ventricular Cardiomyopathy in Mice.
Ellawindy A; Satoh K; Sunamura S; Kikuchi N; Suzuki K; Minami T; Ikeda S; Tanaka S; Shimizu T; Enkhjargal B; Miyata S; Taguchi Y; Handoh T; Kobayashi K; Kobayashi K; Nakayama K; Miura M; Shimokawa H
Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2172-84. PubMed ID: 26315406
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
[TBL] [Abstract][Full Text] [Related]
7. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Ca
Kim JC; Pérez-Hernández M; Alvarado FJ; Maurya SR; Montnach J; Yin Y; Zhang M; Lin X; Vasquez C; Heguy A; Liang FX; Woo SH; Morley GE; Rothenberg E; Lundby A; Valdivia HH; Cerrone M; Delmar M
Circulation; 2019 Sep; 140(12):1015-1030. PubMed ID: 31315456
[TBL] [Abstract][Full Text] [Related]
9. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
Kirchhof P; Fabritz L; Zwiener M; Witt H; Schäfers M; Zellerhoff S; Paul M; Athai T; Hiller KH; Baba HA; Breithardt G; Ruiz P; Wichter T; Levkau B
Circulation; 2006 Oct; 114(17):1799-806. PubMed ID: 17030684
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.
Joshi-Mukherjee R; Coombs W; Musa H; Oxford E; Taffet S; Delmar M
Heart Rhythm; 2008 Dec; 5(12):1715-23. PubMed ID: 19084810
[TBL] [Abstract][Full Text] [Related]
11. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.
Itzhaki I; Maizels L; Huber I; Gepstein A; Arbel G; Caspi O; Miller L; Belhassen B; Nof E; Glikson M; Gepstein L
J Am Coll Cardiol; 2012 Sep; 60(11):990-1000. PubMed ID: 22749309
[TBL] [Abstract][Full Text] [Related]
12. Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC.
Pérez-Hernández M; van Opbergen CJM; Bagwan N; Vissing CR; Marrón-Liñares GM; Zhang M; Torres Vega E; Sorrentino A; Drici L; Sulek K; Zhai R; Hansen FB; Christensen AH; Boesgaard S; Gustafsson F; Rossing K; Small EM; Davies MJ; Rothenberg E; Sato PY; Cerrone M; Jensen THL; Qvortrup K; Bundgaard H; Delmar M; Lundby A
Circulation; 2022 Sep; 146(11):851-867. PubMed ID: 35959657
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism.
MacRae CA; Birchmeier W; Thierfelder L
J Clin Invest; 2006 Jul; 116(7):1825-8. PubMed ID: 16823481
[TBL] [Abstract][Full Text] [Related]
14. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.
Syrris P; Ward D; Asimaki A; Sen-Chowdhry S; Ebrahim HY; Evans A; Hitomi N; Norman M; Pantazis A; Shaw AL; Elliott PM; McKenna WJ
Circulation; 2006 Jan; 113(3):356-64. PubMed ID: 16415378
[TBL] [Abstract][Full Text] [Related]
15. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations.
Kirchner F; Schuetz A; Boldt LH; Martens K; Dittmar G; Haverkamp W; Thierfelder L; Heinemann U; Gerull B
Circ Cardiovasc Genet; 2012 Aug; 5(4):400-11. PubMed ID: 22781308
[TBL] [Abstract][Full Text] [Related]
16. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
Asimaki A; Protonotarios A; James CA; Chelko SP; Tichnell C; Murray B; Tsatsopoulou A; Anastasakis A; te Riele A; Kléber AG; Judge DP; Calkins H; Saffitz JE
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003688. PubMed ID: 26850880
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.
Gerull B; Heuser A; Wichter T; Paul M; Basson CT; McDermott DA; Lerman BB; Markowitz SM; Ellinor PT; MacRae CA; Peters S; Grossmann KS; Drenckhahn J; Michely B; Sasse-Klaassen S; Birchmeier W; Dietz R; Breithardt G; Schulze-Bahr E; Thierfelder L
Nat Genet; 2004 Nov; 36(11):1162-4. PubMed ID: 15489853
[TBL] [Abstract][Full Text] [Related]
20. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2.
Cruz FM; Sanz-Rosa D; Roche-Molina M; García-Prieto J; García-Ruiz JM; Pizarro G; Jiménez-Borreguero LJ; Torres M; Bernad A; Ruíz-Cabello J; Fuster V; Ibáñez B; Bernal JA
J Am Coll Cardiol; 2015 Apr; 65(14):1438-50. PubMed ID: 25857910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
